Follow
Eileen M. O'Reilly
Eileen M. O'Reilly
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, ...
New England Journal of Medicine 381 (4), 317-327, 2019
21082019
Pancreatic cancer: a review
W Park, A Chawla, EM O’Reilly
Jama 326 (9), 851-862, 2021
10932021
Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology
MA Tempero, MP Malafa, M Al-Hawary, H Asbun, A Bain, SW Behrman, ...
Journal of the National Comprehensive Cancer Network 15 (8), 1028-1061, 2017
10092017
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)
HL Kindler, D Niedzwiecki, D Hollis, S Sutherland, D Schrag, H Hurwitz, ...
Journal of Clinical Oncology 28 (22), 3617-3622, 2010
10022010
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection
I Endo, M Gonen, AC Yopp, KM Dalal, Q Zhou, D Klimstra, M D'Angelica, ...
Annals of surgery 248 (1), 84-96, 2008
9372008
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
9202020
Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a …
AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti, B Fruth, JA Meyerhardt, ...
Jama 317 (23), 2392-2401, 2017
8632017
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group–directed intergroup trial …
PA Philip, J Benedetti, CL Corless, R Wong, EM O'Reilly, PJ Flynn, ...
Journal of clinical oncology 28 (22), 3605-3610, 2010
7382010
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
AA Khorana, GA Soff, AK Kakkar, S Vadhan-Raj, H Riess, T Wun, ...
New England Journal of Medicine 380 (8), 720-728, 2019
7012019
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma
MA Shah, RK Ramanathan, DH Ilson, A Levnor, D D'Adamo, E O'Reilly, ...
Journal of Clinical Oncology 24 (33), 5201-5206, 2006
5812006
Gallbladder cancer (GBC): 10‐year experience at memorial Sloan‐Kettering cancer centre (MSKCC)
A Duffy, M Capanu, GK Abou‐Alfa, D Huitzil, W Jarnagin, Y Fong, ...
Journal of surgical oncology 98 (7), 485-489, 2008
5542008
Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial
EM O’Reilly, DY Oh, N Dhani, DJ Renouf, MA Lee, W Sun, G Fisher, ...
JAMA oncology 5 (10), 1431-1438, 2019
5522019
Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, ...
Journal of clinical oncology 37 (4), 286-295, 2019
5452019
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
F Fata, E O'Reilly, D Ilson, D Pfister, D Leffel, DP Kelsen, GK Schwartz, ...
Cancer 86 (10), 2034-2037, 1999
5361999
Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
JM Herman, DT Chang, KA Goodman, AS Dholakia, SP Raman, ...
Cancer 121 (7), 1128-1137, 2015
5192015
Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB …
AP Venook, D Niedzwiecki, F Innocenti, B Fruth, C Greene, BH O'Neil, ...
Journal of Clinical Oncology 34 (15_suppl), 3504-3504, 2016
5022016
Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, ...
Jama 318 (9), 825-835, 2017
4872017
Intrahepatic cholangiocarcinoma: expert consensus statement
SM Weber, D Ribero, EM O'Reilly, N Kokudo, M Miyazaki, TM Pawlik
Hpb 17 (8), 669-680, 2015
4822015
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ...
Nature 618 (7963), 144-150, 2023
4702023
Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention
MA Lowery, R Ptashkin, E Jordan, MF Berger, A Zehir, M Capanu, ...
Clinical Cancer Research 24 (17), 4154-4161, 2018
4602018
The system can't perform the operation now. Try again later.
Articles 1–20